Craft

Codex DNA

Stock Price

$1.5

2024-10-29

Market Capitalization

$2.7 M

2024-10-29

Revenue

$27.5 M

FY, 2023

Codex DNA Summary

Company Summary

Overview
Codex DNA (formerly SGI-DNA) is a biology company that provides solutions for DNA, RNA, and protein synthesis. It offers BioXp system for the development of such products as antibody-based biologics, mRNA-based vaccines and therapeutics, and precision medicines. The company provides biology instruments, reagents, and associated products, and related services to pharmaceutical and academic laboratories.
Type
Public
Status
Active
Founded
2013
HQ
San Diego, CA, US | view all locations
Website
https://codexdna.com/
Cybersecurity rating
Sectors

Key People

  • Todd R. Nelson

    Todd R. Nelson, Chief Executive Officer and Director

  • Daniel G. Gibson

    Daniel G. Gibson, Chief Technology Officer

  • Timothy E. Cloutier

    Timothy E. Cloutier, SVP Commercial Operations

  • Laurence Warden

    Laurence Warden, VP Engineering, Instrumentation

LocationsView all

1 location detected

  • San Diego, CA HQ

    United States

    9535 Waples St #100

Codex DNA Financials

Summary Financials

Revenue (Q3, 2024)
$1.6M
Gross profit (Q3, 2024)
$1.0M
Net income (Q3, 2024)
($6.6M)
Cash (Q3, 2024)
$3.7M
EBIT (Q3, 2024)
($5.5M)
Enterprise value
$6.9M

Footer menu